Cargando…

A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy

Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngoepe, Malebogo, Passos, Andreas, Balabani, Stavroula, King, Jesse, Lynn, Anastasia, Moodley, Jasanth, Swanson, Liam, Bezuidenhout, Deon, Davies, Neil H., Franz, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692440/
https://www.ncbi.nlm.nih.gov/pubmed/31448288
http://dx.doi.org/10.3389/fcvm.2019.00104
_version_ 1783443553062486016
author Ngoepe, Malebogo
Passos, Andreas
Balabani, Stavroula
King, Jesse
Lynn, Anastasia
Moodley, Jasanth
Swanson, Liam
Bezuidenhout, Deon
Davies, Neil H.
Franz, Thomas
author_facet Ngoepe, Malebogo
Passos, Andreas
Balabani, Stavroula
King, Jesse
Lynn, Anastasia
Moodley, Jasanth
Swanson, Liam
Bezuidenhout, Deon
Davies, Neil H.
Franz, Thomas
author_sort Ngoepe, Malebogo
collection PubMed
description Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countries are also affected and in these settings, younger individuals are at high risk. Currently, interventions for MI prolong the time to heart failure. Regenerative medicine and stem cell therapy have the potential to mitigate the effects of MI and to significantly improve the quality of life for patients. The main drawback with these therapies is that many of the injected cells are lost due to the vigorous motion of the heart. Great effort has been directed toward the development of scaffolds which can be injected alongside stem cells, in an attempt to improve retention and cell engraftment. In some cases, the scaffold alone has been seen to improve heart function. This study focuses on a synthetic polyethylene glycol (PEG) based hydrogel which is injected into the heart to improve left ventricular function following MI. Many studies in literature characterize PEG as a Newtonian fluid within a specified shear rate range, on the macroscale. The aim of the study is to characterize the flow of a 20 kDa PEG on the microscale, where the behavior is likely to deviate from macroscale flow patterns. Micro particle image velocimetry (μPIV) is used to observe flow behavior in microchannels, representing the gaps in myocardial tissue. The fluid exhibits non-Newtonian, shear-thinning behavior at this scale. Idealized two-dimensional computational fluid dynamics (CFD) models of PEG flow in microchannels are then developed and validated using the μPIV study. The validated computational model is applied to a realistic, microscopy-derived myocardial tissue model. From the realistic tissue reconstruction, it is evident that the myocardial flow region plays an important role in the distribution of PEG, and therefore, in the retention of material.
format Online
Article
Text
id pubmed-6692440
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66924402019-08-23 A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy Ngoepe, Malebogo Passos, Andreas Balabani, Stavroula King, Jesse Lynn, Anastasia Moodley, Jasanth Swanson, Liam Bezuidenhout, Deon Davies, Neil H. Franz, Thomas Front Cardiovasc Med Cardiovascular Medicine Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countries are also affected and in these settings, younger individuals are at high risk. Currently, interventions for MI prolong the time to heart failure. Regenerative medicine and stem cell therapy have the potential to mitigate the effects of MI and to significantly improve the quality of life for patients. The main drawback with these therapies is that many of the injected cells are lost due to the vigorous motion of the heart. Great effort has been directed toward the development of scaffolds which can be injected alongside stem cells, in an attempt to improve retention and cell engraftment. In some cases, the scaffold alone has been seen to improve heart function. This study focuses on a synthetic polyethylene glycol (PEG) based hydrogel which is injected into the heart to improve left ventricular function following MI. Many studies in literature characterize PEG as a Newtonian fluid within a specified shear rate range, on the macroscale. The aim of the study is to characterize the flow of a 20 kDa PEG on the microscale, where the behavior is likely to deviate from macroscale flow patterns. Micro particle image velocimetry (μPIV) is used to observe flow behavior in microchannels, representing the gaps in myocardial tissue. The fluid exhibits non-Newtonian, shear-thinning behavior at this scale. Idealized two-dimensional computational fluid dynamics (CFD) models of PEG flow in microchannels are then developed and validated using the μPIV study. The validated computational model is applied to a realistic, microscopy-derived myocardial tissue model. From the realistic tissue reconstruction, it is evident that the myocardial flow region plays an important role in the distribution of PEG, and therefore, in the retention of material. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692440/ /pubmed/31448288 http://dx.doi.org/10.3389/fcvm.2019.00104 Text en Copyright © 2019 Ngoepe, Passos, Balabani, King, Lynn, Moodley, Swanson, Bezuidenhout, Davies and Franz. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Ngoepe, Malebogo
Passos, Andreas
Balabani, Stavroula
King, Jesse
Lynn, Anastasia
Moodley, Jasanth
Swanson, Liam
Bezuidenhout, Deon
Davies, Neil H.
Franz, Thomas
A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title_full A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title_fullStr A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title_full_unstemmed A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title_short A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
title_sort preliminary computational investigation into the flow of peg in rat myocardial tissue for regenerative therapy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692440/
https://www.ncbi.nlm.nih.gov/pubmed/31448288
http://dx.doi.org/10.3389/fcvm.2019.00104
work_keys_str_mv AT ngoepemalebogo apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT passosandreas apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT balabanistavroula apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT kingjesse apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT lynnanastasia apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT moodleyjasanth apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT swansonliam apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT bezuidenhoutdeon apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT daviesneilh apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT franzthomas apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT ngoepemalebogo preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT passosandreas preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT balabanistavroula preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT kingjesse preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT lynnanastasia preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT moodleyjasanth preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT swansonliam preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT bezuidenhoutdeon preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT daviesneilh preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy
AT franzthomas preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy